Thermo Fisher Scientific Company Profile (NYSE:TMO)

About Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific logoThermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NYSE:TMO
  • CUSIP: 88355610
  • Web:
  • Market Cap: $68.76 billion
  • Outstanding Shares: 391,219,000
Average Prices:
  • 50 Day Moving Avg: $172.96
  • 200 Day Moving Avg: $157.13
  • 52 Week Range: $139.07 - $176.92
  • Trailing P/E Ratio: 31.69
  • Foreward P/E Ratio: 17.22
  • P/E Growth: 1.75
Sales & Book Value:
  • Annual Revenue: $18.74 billion
  • Price / Sales: 3.67
  • Book Value: $55.71 per share
  • Price / Book: 3.16
  • Annual Dividend: $0.60
  • Dividend Yield: 0.3%
  • EBIDTA: $4.69 billion
  • Net Margins: 11.58%
  • Return on Equity: 15.73%
  • Return on Assets: 7.44%
  • Debt-to-Equity Ratio: 0.70%
  • Current Ratio: 1.37%
  • Quick Ratio: 0.93%
  • Average Volume: 1.50 million shs.
  • Beta: 1.05
  • Short Ratio: 2.23

Frequently Asked Questions for Thermo Fisher Scientific (NYSE:TMO)

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific announced a quarterly dividend on Thursday, May 18th. Shareholders of record on Thursday, June 15th will be paid a dividend of $0.15 per share on Monday, July 17th. This represents a $0.60 annualized dividend and a dividend yield of 0.34%. The ex-dividend date is Tuesday, June 13th. View Thermo Fisher Scientific's Dividend History.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc (NYSE:TMO) announced its earnings results on Wednesday, April, 26th. The company reported $2.08 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $2.02 by $0.06. The firm earned $4.77 billion during the quarter, compared to analyst estimates of $4.68 billion. Thermo Fisher Scientific had a return on equity of 15.73% and a net margin of 11.58%. The company's quarterly revenue was up 10.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.80 earnings per share. View Thermo Fisher Scientific's Earnings History.

When will Thermo Fisher Scientific make its next earnings announcement?

Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, July, 26th 2017. View Earnings Estimates for Thermo Fisher Scientific.

What guidance has Thermo Fisher Scientific issued on next quarter's earnings?

Thermo Fisher Scientific issued an update on its FY17 earnings guidance on Wednesday, April, 26th. The company provided earnings per share guidance of $9.12-9.28 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.17. The company issued revenue guidance of $19.51-19.71, compared to the consensus revenue estimate of $19.53 billion.

Where is Thermo Fisher Scientific's stock going? Where will Thermo Fisher Scientific's stock price be in 2017?

15 analysts have issued 12 month target prices for Thermo Fisher Scientific's shares. Their forecasts range from $162.00 to $200.00. On average, they expect Thermo Fisher Scientific's stock price to reach $184.29 in the next year. View Analyst Ratings for Thermo Fisher Scientific.

What are analysts saying about Thermo Fisher Scientific stock?

Here are some recent quotes from research analysts about Thermo Fisher Scientific stock:

  • 1. According to Zacks Investment Research, "Thermo Fisher ended the year 2016 on a mixed note with adjusted earnings ahead of the Zacks Consensus Estimate and sales lagging the same. We remain encouraged by the company’s recent product launches along with strong emerging markets growth. In this regard, over the past three months, Thermo Fisher traded neck on neck with the Zacks categorized Medical Instruments industry. However, the company has started to outdo the broader industry on strong fourth-quarter bottom line performance and a solid outlook. We also look forward to Thermo Fisher’s acquisition of FEI Company which is going to boost its performance in life-science research. We also await the integration and expected synergy of Affimetrix. On the flip side, as expected, Thermo Fisher’s top-line performance in the quarter was affected by four less selling days resulting in flat organic growth. Competitive pressure and currency headwinds add further woes." (2/13/2017)
  • 2. Evercore ISI analysts commented, "When all is said in done we will remember 4Q as being generally uneventful, with guidance coming in better than feared as investors had become concerned re the impact from slowing biopharma demand (didn't really occur), mixed A&G trends and an incremental headwind from Fx. The level of consistency we see from TMO is unusual in this challenging healthcare environment and likely helps to justify valuation that is certainly not inexpensive on an EV / EBITDA basis (particularly in a rising rate world). That being said with so few places to hide in a difficult healthcare tape, we would expect TMO's superior EPS growth to help shares to remain a preferred equity, particularly given its status as a visible compounder. Thus despite today's sharp move in shares (up a bit more than we would have anticipated) we reiterate our Buy rating as risk / reward continues to be asymmetrically biased upward." (1/31/2017)

Who are some of Thermo Fisher Scientific's key competitors?

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the folowing people:

  • Jim P. Manzi, Independent Chairman of the Board
  • Marc N. Casper, President, Chief Executive Officer, Director
  • Stephen Williamson, Chief Financial Officer, Senior Vice President
  • Mark P. Stevenson, Executive Vice President, President, Life Sciences Solutions
  • Seth H. Hoogasian, Senior Vice President, General Counsel, Secretary
  • Patrick M. Durbin, Senior Vice President, President - Specialty Diagnostics
  • Thomas W. Loewald, Senior Vice President, Chief Commercial Officer
  • Daniel P. Shine, Senior Vice President, President, Analytical Instruments
  • Peter E. Hornstra, Vice President, Chief Accounting Officer
  • Dion J. Weisler, Director

Who owns Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock is owned by a number of of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (7.27%), Vanguard Group Inc. (6.64%), BlackRock Inc. (5.88%), State Street Corp (4.11%), Wellington Management Group LLP (1.92%) and Primecap Management Co. CA (1.35%). Company insiders that own Thermo Fisher Scientific stock include Alan J Malus, Andrew J Thomson, C Martin Harris, Daniel P Shine, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Scott M Sperling, Seth H Hoogasian, Stephen Williamson, Thomas W Loewald and William G Parrett. View Institutional Ownership Trends for Thermo Fisher Scientific.

Who sold Thermo Fisher Scientific stock? Who is selling Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Glenview Capital Management LLC, Levin Capital Strategies L.P., APG Asset Management N.V., Russell Investments Group Ltd., Westfield Capital Management Co. LP, State Treasurer State of Michigan and Massachusetts Financial Services Co. MA. Company insiders that have sold Thermo Fisher Scientific stock in the last year include C Martin Harris, Daniel P Shine, Marc N Casper, Peter M Wilver, Seth H Hoogasian, Stephen Williamson and Thomas W Loewald. View Insider Buying and Selling for Thermo Fisher Scientific.

Who bought Thermo Fisher Scientific stock? Who is buying Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., C WorldWide Group Holding A S, Veritas Asset Management LLP, Vanguard Group Inc., Renaissance Technologies LLC, Winslow Capital Management LLC, NN Investment Partners Holdings N.V. and Wellington Management Group LLP. View Insider Buying and Selling for Thermo Fisher Scientific.

How do I buy Thermo Fisher Scientific stock?

Shares of Thermo Fisher Scientific can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of Thermo Fisher Scientific stock can currently be purchased for approximately $175.77.

MarketBeat Community Rating for Thermo Fisher Scientific (NYSE TMO)
Community Ranking:  3.5 out of 5 (   )
Outperform Votes:  427 (Vote Outperform)
Underperform Votes:  184 (Vote Underperform)
Total Votes:  611
MarketBeat's community ratings are surveys of what our community members think about Thermo Fisher Scientific and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Thermo Fisher Scientific (NYSE:TMO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 12 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.93)
Consensus Price Target: $184.29 (4.84% upside)

Analysts' Ratings History for Thermo Fisher Scientific (NYSE:TMO)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/10/2017Deutsche Bank AGSet Price TargetBuy$200.00LowView Rating Details
5/18/2017Cantor FitzgeraldInitiated CoverageOverweight -> Overweight$194.00LowView Rating Details
5/17/2017Jefferies Group LLCReiterated RatingHold$175.00LowView Rating Details
5/9/2017Barclays PLCReiterated RatingOverweight -> Overweight$175.00 -> $190.00LowView Rating Details
5/9/2017Bank of America CorporationBoost Price TargetBuy$190.00 -> $200.00LowView Rating Details
4/29/2017Cowen and CompanyReiterated RatingOutperform$175.00 -> $185.00LowView Rating Details
4/28/2017Morgan StanleyBoost Price TargetOverweight$186.00 -> $192.00LowView Rating Details
4/28/2017BTIG ResearchBoost Price TargetBuy$180.00 -> $190.00LowView Rating Details
4/27/2017Leerink SwannSet Price TargetBuy$187.00LowView Rating Details
1/31/2017Evercore ISIBoost Price TargetBuy$160.00 -> $162.00N/AView Rating Details
12/12/2016Goldman Sachs Group, Inc. (The)Reiterated RatingConviction-Buy -> Conviction-Buy$170.00 -> $168.00N/AView Rating Details
9/22/2016J P Morgan Chase & CoInitiated CoverageOverweight$180.00N/AView Rating Details
9/9/2016Cleveland ResearchDowngradeBuy -> NeutralN/AView Rating Details
7/29/2016Citigroup Inc.Boost Price TargetBuy$160.00 -> $182.00N/AView Rating Details
7/28/2016MizuhoSet Price TargetBuy$170.00 -> $175.00N/AView Rating Details
3/2/2016Topeka Capital MarketsBoost Price TargetBuy$145.00 -> $155.00N/AView Rating Details
1/29/2016Stifel NicolausLower Price Target$158.00 -> $150.00N/AView Rating Details
1/29/2016KeyCorpLower Price TargetOverweight$152.00 -> $150.00N/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageOutperform$168.00N/AView Rating Details
10/6/2015ArgusInitiated CoverageBuy$145.00N/AView Rating Details
7/23/2015Robert W. BairdBoost Price TargetOutperform$148.00 -> $160.00N/AView Rating Details
(Data available from 6/28/2015 forward)


Earnings History for Thermo Fisher Scientific (NYSE:TMO)
Earnings by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Earnings History by Quarter for Thermo Fisher Scientific (NYSE TMO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017Q1 2017$2.02$2.08$4.68 billion$4.77 billionViewN/AView Earnings Details
1/31/2017Q416$2.38$2.41$4.98 billion$4.95 billionViewN/AView Earnings Details
10/27/2016Q316$1.97$2.03$4.39 billion$4.49 billionViewListenView Earnings Details
7/28/2016Q216$2.01$2.03$4.50 billion$4.54 billionViewListenView Earnings Details
4/28/2016Q116$1.74$1.80$4.11 billion$4.29 billionViewListenView Earnings Details
1/28/2016Q415$2.11$2.12$4.55 billion$4.65 billionViewListenView Earnings Details
10/21/2015Q315$1.79$1.80$4.10 billion$4.12 billionViewListenView Earnings Details
7/22/2015Q215$1.78$1.84$4.17 billion$4.27 billionViewListenView Earnings Details
4/22/2015Q115$1.61$1.63$4.01 billion$3.92 billionViewN/AView Earnings Details
1/29/2015Q414$1.94$1.99$4.39 billion$4.49 billionViewN/AView Earnings Details
10/22/2014Q314$1.69$1.71$4.21 billion$4.17 billionViewListenView Earnings Details
7/23/2014Q214$1.62$1.72$4.25 billion$4.32 billionViewN/AView Earnings Details
4/23/2014Q114$1.40$1.53$3.74 billion$3.90 billionViewN/AView Earnings Details
1/31/2014Q413$1.38$1.43$3.31 billion$3.47 billionViewN/AView Earnings Details
10/23/2013Q313$1.28$1.30$3.18 billion$3.19 billionViewListenView Earnings Details
7/24/2013Q2 2013$1.30$1.32$3.22 billion$3.24 billionViewListenView Earnings Details
4/24/2013Q1 2013$1.29$1.37$3.17 billion$3.19 billionViewListenView Earnings Details
1/31/2013Q4 2012$1.28$1.36$3.13 billion$3.26 billionViewListenView Earnings Details
10/24/2012$1.16$1.19ViewN/AView Earnings Details
7/25/2012$1.16$1.22ViewN/AView Earnings Details
4/25/2012$1.11$1.17ViewN/AView Earnings Details
2/1/2012$1.16$1.18ViewN/AView Earnings Details
10/26/2011$1.07$1.07ViewN/AView Earnings Details
7/27/2011$0.98$0.99ViewN/AView Earnings Details
4/27/2011$0.88$0.92ViewN/AView Earnings Details
2/2/2011$0.95$1.00ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Thermo Fisher Scientific (NYSE:TMO)
2017 EPS Consensus Estimate: $9.21
2018 EPS Consensus Estimate: $10.16
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$2.02$2.16$2.07
Q2 20173$2.22$2.27$2.25
Q3 20173$2.24$2.27$2.26
Q4 20173$2.58$2.68$2.63
Q1 20182$2.30$2.44$2.37
Q2 20182$2.49$2.53$2.51
Q3 20182$2.48$2.50$2.49
Q4 20182$2.70$2.87$2.79
(Data provided by Zacks Investment Research)


Current Dividend Information for Thermo Fisher Scientific (NYSE:TMO)
Next Dividend:7/17/2017
Annual Dividend:$0.60
Dividend Yield:0.34%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:10.95% (Trailing 12 Months of Earnings)
6.51% (Based on This Year's Estimates)
5.88% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Dividend History by Quarter for Thermo Fisher Scientific (NYSE TMO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Thermo Fisher Scientific (NYSE:TMO)
Insider Ownership Percentage: 0.49%
Institutional Ownership Percentage: 86.94%
Insider Trades by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Insider Trades by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/5/2017Stephen WilliamsonCFOSell2,500$176.26$440,650.00View SEC Filing  
6/1/2017Marc N CasperCEOSell20,000$172.79$3,455,800.00View SEC Filing  
5/24/2017Daniel P ShineInsiderSell4,688$171.88$805,773.44View SEC Filing  
4/27/2017Thomas W LoewaldInsiderSell1,532$168.76$258,540.32View SEC Filing  
3/15/2017Marc N CasperCEOSell20,000$158.60$3,172,000.00View SEC Filing  
3/15/2017Peter M WilverVPSell9,079$160.73$1,459,267.67View SEC Filing  
3/10/2017Peter M WilverVPSell9,987$158.18$1,579,743.66View SEC Filing  
3/8/2017Thomas W LoewaldInsiderSell7,675$157.39$1,207,968.25View SEC Filing  
3/6/2017Seth H HoogasianVPSell3,142$158.71$498,666.82View SEC Filing  
3/6/2017Stephen WilliamsonCFOSell2,500$158.71$396,775.00View SEC Filing  
3/6/2017Thomas W LoewaldSVPSell4,049$158.71$642,616.79View SEC Filing  
9/2/2016Marc N CasperCEOSell28,797$151.01$4,348,634.97View SEC Filing  
9/1/2016Marc N CasperCEOSell30,000$151.17$4,535,100.00View SEC Filing  
8/29/2016Daniel P ShineSVPSell1,699$152.28$258,723.72View SEC Filing  
8/29/2016Seth H HoogasianVPSell2,270$152.28$345,675.60View SEC Filing  
8/29/2016Thomas W LoewaldInsiderSell3,256$152.28$495,823.68View SEC Filing  
8/26/2016Thomas W LoewaldInsiderSell913$151.92$138,702.96View SEC Filing  
8/10/2016Seth H HoogasianVPSell5,023$156.00$783,588.00View SEC Filing  
8/5/2016C Martin HarrisDirectorSell390$157.33$61,358.70View SEC Filing  
7/13/2016Thomas W LoewaldSVPSell8,025$155.00$1,243,875.00View SEC Filing  
7/5/2016Marc N CasperCEOSell20,000$147.69$2,953,800.00View SEC Filing  
7/1/2016Marc N CasperCEOSell30,000$148.85$4,465,500.00View SEC Filing  
6/15/2016Daniel P ShineSVPSell6,900$148.31$1,023,339.00View SEC Filing  
6/10/2016Peter M WilverVPSell68,200$152.38$10,392,316.00View SEC Filing  
6/3/2016Jim P ManziDirectorSell1,137$153.00$173,961.00View SEC Filing  
6/2/2016Thomas W LoewaldSVPSell15,000$152.84$2,292,600.00View SEC Filing  
5/16/2016Peter E HornstraCAOSell7,811$150.00$1,171,650.00View SEC Filing  
4/26/2016Daniel P ShineSVPSell6,013$146.00$877,898.00View SEC Filing  
4/5/2016Seth H HoogasianVPSell10,000$141.86$1,418,600.00View SEC Filing  
4/4/2016Patrick M DurbinSVPSell16,250$142.18$2,310,425.00View SEC Filing  
3/21/2016Stephen WilliamsonCFOSell10,708$139.50$1,493,766.00View SEC Filing  
3/14/2016Marc N CasperCEOSell30,000$139.28$4,178,400.00View SEC Filing  
3/10/2016Alan J MalusEVPSell25,925$139.05$3,604,871.25View SEC Filing  
3/9/2016Alan J MalusEVPSell15,446$138.50$2,139,271.00View SEC Filing  
3/3/2016Scott M SperlingDirectorSell5,350$137.90$737,765.00View SEC Filing  
3/3/2016Thomas W LoewaldSVPSell3,625$137.28$497,640.00View SEC Filing  
3/1/2016Seth H HoogasianVPSell2,951$135.00$398,385.00View SEC Filing  
2/1/2016Alan J. MalusEVPSell103,400$130.24$13,466,816.00View SEC Filing  
1/15/2016Daniel P. ShineSVPSell6,000$131.77$790,620.00View SEC Filing  
12/14/2015Thomas W. LoewaldSVPSell13,013$134.18$1,746,084.34View SEC Filing  
12/11/2015William G ParrettDirectorBuy1,000$134.16$134,160.00View SEC Filing  
12/7/2015Alan J. MalusEVPSell82,300$135.49$11,150,827.00View SEC Filing  
11/4/2015Seth H HoogasianVPSell1,692$135.00$228,420.00View SEC Filing  
11/3/2015C Martin HarrisDirectorSell531$134.35$71,339.85View SEC Filing  
11/2/2015Jim P. ManziDirectorSell3,050$133.49$407,144.50View SEC Filing  
9/17/2015Marc N CasperCEOSell25,000$130.00$3,250,000.00View SEC Filing  
8/28/2015Alan J MalusEVPSell4,557$127.55$581,245.35View SEC Filing  
7/14/2015Andrew J ThomsonSVPSell5,000$135.23$676,150.00View SEC Filing  
7/14/2015Peter E HornstraCAOSell7,381$136.02$1,003,963.62View SEC Filing  
6/3/2015Tyler JacksDirectorSell15,000$129.95$1,949,250.00View SEC Filing  
6/1/2015Alan J MalusEVPSell40,350$129.54$5,226,939.00View SEC Filing  
5/26/2015Thomas J LynchDirectorSell5,000$131.09$655,450.00View SEC Filing  
5/21/2015Peter M WilverCFOSell28,100$133.00$3,737,300.00View SEC Filing  
4/23/2015Thomas J LynchDirectorSell5,000$130.15$650,750.00View SEC Filing  
4/21/2015Seth H HoogasianVPSell13,256$135.00$1,789,560.00View SEC Filing  
4/13/2015Alan J MalusEVPSell11,032$133.67$1,474,647.44View SEC Filing  
4/13/2015Andrew J ThomsonSVPSell12,425$133.50$1,658,737.50View SEC Filing  
4/1/2015Marc N CasperCEOSell20,000$131.89$2,637,800.00View SEC Filing  
3/30/2015Thomas J LynchDirectorSell5,000$134.40$672,000.00View SEC Filing  
3/30/2015Thomas W LoewaldSVPSell5,307$134.40$713,260.80View SEC Filing  
3/9/2015Alan J MalusEVPSell14,479$128.11$1,854,904.69View SEC Filing  
2/23/2015Edward A PesickaSVPSell28,713$130.93$3,759,393.09View SEC Filing  
2/20/2015Peter M WilverCFOSell50,700$130.12$6,597,084.00View SEC Filing  
2/20/2015Thomas W LoewaldSVPSell15,037$127.94$1,923,833.78View SEC Filing  
2/5/2015Alan J MalusEVPSell50,000$126.83$6,341,500.00View SEC Filing  
12/18/2014Alan J MalusEVPSell11,618$125.20$1,454,573.60View SEC Filing  
11/19/2014Peter E HornstraCAOSell8,363$125.00$1,045,375.00View SEC Filing  
8/27/2014Alan J MalusEVPSell13,115$120.61$1,581,800.15View SEC Filing  
8/27/2014Seth H HoogasianVPSell10,577$120.77$1,277,384.29View SEC Filing  
8/27/2014Thomas W LoewaldSVPSell2,349$120.90$283,994.10View SEC Filing  
7/30/2014Seth H HoogasianVPSell5,103$123.82$631,853.46View SEC Filing  
7/25/2014Thomas W LoewaldSVPSell6,000$125.23$751,380.00View SEC Filing  
4/29/2014Jim ManziDirectorSell3,000$114.85$344,550.00View SEC Filing  
4/28/2014Thomas LoewaldSVPSell8,688$114.49$994,689.12View SEC Filing  
3/24/2014Edward PesickaSVPSell80,044$120.75$9,665,313.00View SEC Filing  
2/26/2014Alan MalusEVPSell7,640$124.11$948,200.40View SEC Filing  
2/14/2014Andrew ThomsonSVPSell16,725$123.14$2,059,516.50View SEC Filing  
2/10/2014Peter HornstraCAOSell9,234$117.72$1,087,026.48View SEC Filing  
2/7/2014Marc CasperCEOSell208,765$115.70$24,154,110.50View SEC Filing  
2/7/2014Peter WilverCFOSell91,897$115.21$10,587,453.37View SEC Filing  
2/6/2014Thomas LoewaldSVPSell22,437$114.24$2,563,202.88View SEC Filing  
2/6/2014William ParrettDirectorSell18,000$114.33$2,057,940.00View SEC Filing  
9/16/2013Alan MalusEVPSell4,000$91.87$367,480.00View SEC Filing  
8/15/2013Alan MalusEVPSell4,000$91.11$364,440.00View SEC Filing  
7/24/2013Edward A PesickaSVPSell80,700$91.00$7,343,700.00View SEC Filing  
6/17/2013Marc N CasperCEOSell43,396$85.58$3,713,829.68View SEC Filing  
6/17/2013Seth H HoogasianVPSell35,431$85.59$3,032,539.29View SEC Filing  
6/10/2013Judy C LewentDirectorSell15,000$85.19$1,277,850.00View SEC Filing  
6/7/2013Edward A PesickaSVPSell167,980$85.28$14,325,334.40View SEC Filing  
5/24/2013C Martin HarrisDirectorSell1,260$87.21$109,884.60View SEC Filing  
5/15/2013Alan J MalusEVPSell4,000$84.43$337,720.00View SEC Filing  
5/14/2013Scott M SperlingDirectorSell8,000$84.65$677,200.00View SEC Filing  
5/7/2013Andrew J ThomsonSVPSell12,700$83.65$1,062,355.00View SEC Filing  
5/7/2013Jim P ManziDirectorSell7,500$82.78$620,850.00View SEC Filing  
11/1/2012Marc N CasperCEOSell125,000$62.49$7,811,250.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Thermo Fisher Scientific (NYSE:TMO)
Latest Headlines for Thermo Fisher Scientific (NYSE:TMO)
DateHeadline logoThermo Fisher Scientific Inc (TMO) Downgraded to Buy at BidaskClub - June 27 at 4:04 PM logoThermo Fisher Scientific Inc to Post FY2018 Earnings of $10.21 Per Share, Cantor Fitzgerald Forecasts (TMO) - June 26 at 7:51 AM logoBRIEF-FDA approves Thermo fisher Scientific's companion diagnostic test to screen multiple non-small cell lung cancer therapies - June 23 at 5:20 AM logo$4.91 Billion in Sales Expected for Thermo Fisher Scientific Inc (TMO) This Quarter - June 21 at 11:02 AM logoETFs with exposure to Thermo Fisher Scientific, Inc. : June 20, 2017 - June 21 at 6:11 AM logoThermo Fisher Scientific Inc (TMO) Receives Consensus Rating of "Buy" from Analysts - June 21 at 12:38 AM logoThermo Fisher Scientific, Inc. :TMO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017 - June 20 at 8:38 AM logoThermo Fisher Scientific Inc (TMO) Expected to Post Earnings of $2.26 Per Share - June 19 at 10:28 AM logoOpGen (OPGN) Reports Supply Agreement with Thermo Fisher Scientific (TMO) for Technology to Advance Acuitas ... - - June 19 at 9:01 AM logoThermo Fisher Scientific Expands Access to Genome Editing with Hands-On Workshop - June 16 at 9:56 AM logoThermo Fisher Scientific, Inc. : TMO-US: Dividend Analysis : June 15th, 2017 (record date) : By the numbers : June 15, 2017 - June 16 at 9:55 AM logoThermo Fisher Scientific Inc (TMO) Ex-Dividend Date Scheduled for June 13, 2017 - Nasdaq - June 13 at 11:31 PM logoPerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria - June 13 at 9:29 AM logoThermo Fisher Scientific Inc (TMO) PT Set at $200.00 by Deutsche Bank AG - June 11 at 10:52 PM logoThermo Fisher Scientific Inc. (TMO) CFO Sells $440,650.00 in Stock - June 6 at 7:51 PM logoInvestors Need To Understand How Huge Thermo Fisher Really Is - Seeking Alpha - June 6 at 11:12 AM logoBRIEF-Thermo Fisher Scientific, Biognosys announce co-marketing agreement - June 5 at 1:11 PM logoThermo Fisher Scientific Raises the Bar in Mass Spectrometry Innovation at ... - June 5 at 1:11 PM logoThermo Fisher Scientific Raises the Bar in Mass Spectrometry Innovation at ASMS 2017 - June 5 at 1:11 PM logoBehind Thermo Fisher’s Recent Stock Performance - June 5 at 1:11 PM logoThermo Fisher Scientific Inc. (TMO) CEO Marc N. Casper Sells 20,000 Shares - June 2 at 7:42 PM logoWhat Does Thermo Fisher Want in the Clinical Mass Spectrometry Business? - June 2 at 3:27 PM logoUnderstanding Thermo Fisher’s Capital Deployment Strategy - June 2 at 3:27 PM logoHow Long Can Thermo Fisher Scientific’s Asia-Pacific Growth Momentum Last? - June 2 at 2:22 AM logoKey Highlights from Thermo Fisher’s 1Q17 Earnings - June 1 at 3:44 AM logoWhy Is Thermo Fisher (TMO) Up 3.7% Since the Last Earnings Report? - May 30 at 8:37 AM logoThermo Fisher Scientific Inc. (TMO) Receives Consensus Rating of "Buy" from Analysts - May 27 at 12:47 AM logoSt. Jude Medical May Establish ABT as a Key Medical Device Player - May 26 at 7:47 AM logoThermo Fisher Scientific Inc. (TMO) Insider Sells $805,773.44 in Stock - May 25 at 7:22 PM logoSeegene To Collaborate With Thermo Fisher To Enter U.S. Diagnostic Market - May 23 at 7:40 PM logoThermo Fisher Scientific (TMO) Collaborates with Seegene on Separate FDA Filings in Conjunction with Allplex and QuantStudio - May 22 at 8:35 AM logoThermo Fisher Scientific Introduces Latest in Capillary Electrophoresis ... - May 22 at 8:35 AM logoCantor Fitzgerald Weighs in on Thermo Fisher Scientific Inc.'s FY2017 Earnings (TMO) - May 22 at 7:18 AM logoEquities Analysts Offer Predictions for Thermo Fisher Scientific Inc.'s Q2 2017 Earnings (TMO) - May 22 at 7:06 AM logoThermo Fisher Scientific Declares Quarterly Dividend - PR Newswire (press release) - May 19 at 11:15 PM logoPhononic CEO shares the key to his company's market penet... - May 19 at 11:15 PM logoThermo Fisher - Multi-Year Dealmaking Spree Continues With Patheon Deal - May 19 at 6:14 PM logoThermo Fisher Initiated with 'Overweight' Rating at Cantor Fitzgerald - May 19 at 1:13 PM logoJefferies Group Comments on Thermo Fisher Scientific Inc.'s FY2017 Earnings (TMO) - May 19 at 7:56 AM logoCantor Fitzgerald Begins Coverage on Thermo Fisher Scientific Inc. (TMO) - May 18 at 5:20 PM logoThermo Fisher Scientific Inc. (TMO) Plans $0.15 Quarterly Dividend - May 18 at 11:50 AM logoThermo Fisher Scientific Inc. (TMO) Receives Hold Rating from Jefferies Group LLC - May 17 at 11:00 AM logoForm SC TO-C Patheon N.V. Filed by: THERMO FISHER SCIENTIFIC INC. - May 16 at 8:13 PM logoThermo Fisher buys Durham's Patheon for $5.2B - May 16 at 8:45 AM logoThermo Fisher (TMO) to Buy Patheon, Expand in Biopharma - May 16 at 8:45 AM logoBRIEF-Thermo Fisher Scientific signs exclusive licensing agreement with Transcriptome Sciences - May 16 at 8:44 AM logoBlog Coverage: Thermo Fisher to Acquire Patheon; Expects to Realize Multiple Synergies from the Transaction - May 16 at 8:44 AM logoThermo Fisher Scientific Strengthens Portfolio of Endotoxin-Free Plasmid DNA Isolation Kits - May 15 at 7:25 PM logo​Waltham's Thermo Fisher buys drug ingredients maker for $5.2B - May 15 at 7:25 PM logoWhy Patheon N.V. Is Soaring Today - May 15 at 7:25 PM



Thermo Fisher Scientific (TMO) Chart for Wednesday, June, 28, 2017

This page was last updated on 6/28/2017 by Staff